Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact

Mohammad Hosein Amirzade-Iranaq; Mehrnaz Hatami; Mohammad Hossein Khosravi; Seyed Moayed Alavian

doi:10.5812/hepatmon.100242

Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact

authors:

Mohammad Hosein Amirzade-Iranaq ^{1
, 2} , Mehrnaz Hatami ³ , Mohammad Hossein Khosravi ² , avatar Seyed Moayed Alavian ^{4
, 5
, *}

1 Universal Network of Interdisciplinary Research in Oral and Maxillofacial Surgery (UNIROMS), Universal Scientific Education and Research Network (USERN), Tehran, Iran

2 Department of Research, Arka Education and Clinical Research Consultants, Tehran, Iran

3 Department of Prosthodontics, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Mollasadra St., Vanak, Tehran, Iran

5 Middle East Liver Diseases (MELD) Center, Tehran, Iran

Hepatitis Monthly: Vol.20, issue 12; e100242

published online: February 7, 2021

article type: Letter

received: December 18, 2019

revised: December 19, 2020

accepted: January 19, 2021

DOI: https://doi.org/10.5812/hepatmon.100242

how to cite: Amirzade-Iranaq M H, Hatami M, Khosravi M H, Alavian S M. Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact. Hepat Mon. 2020;20(12):e100242. https://doi.org/10.5812/hepatmon.100242.

Keywords

Dentistry Hepatitis B Infection Control Vaccination

Footnotes

Authors' Contribution: All authors contributed equally to developing the idea, preparing the draft, and finalizing the manuscript.
Conflict of Interests: None declared by authors.
Ethical Approval: Not applicable.
Funding/Support: None declared by authors.

References

1.
Rezaee-Zavareh MS, Einollahi B. Hepatitis B vaccination: Needs a revision. Hepat Mon. 2014;14(3). https://doi.org/10.5812/hepatmon.17461.
2.
WHO. Global hepatitis report 2017. World Health Organization; 2017. Available from: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/.
3.
World Health O. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine. 2019;37(2):223-5. [PubMed ID: 28743487]. https://doi.org/10.1016/j.vaccine.2017.07.046.
4.
Amirzade-Iranaq MH, Khosravi MH. Infection control status in dental practice: Why to take it serious? Int J Med Rev. 2017;4(1):1-2. https://doi.org/10.29252/ijmr-040101.
5.
Younai FS. Health care-associated transmission of hepatitis B & C viruses in dental care (dentistry). Clin Liver Dis. 2010;14(1):93-104. ix. [PubMed ID: 20123443]. https://doi.org/10.1016/j.cld.2009.11.010.
6.
Dahiya P, Kamal R, Sharma V, Kaur S. "Hepatitis" - Prevention and management in dental practice. J Educ Health Promot. 2015;4:33. [PubMed ID: 26097847]. [PubMed Central ID: PMC4456879]. https://doi.org/10.4103/2277-9531.157188.
7.
O’Brien CR, Lim JK. Prevention and management of hepatitis B in healthcare professionals. Curr Hepatol Rep. 2019;18(1):1-8. https://doi.org/10.1007/s11901-019-00444-6.
8.
Westin J, Aleman S, Castedal M, Duberg AS, Eilard A, Fischler B, et al. Management of hepatitis B virus infection, updated Swedish guidelines. Infect Dis (Lond). 2020;52(1):1-22. [PubMed ID: 31613181]. https://doi.org/10.1080/23744235.2019.1675903.
9.
Babanejad M, Izadi N, Alavian SM. A systematic review and meta-analysis on the prevalence of HBsAg in health care workers from eastern mediterranean and middle eastern countries. Int J Prev Med. 2019;10:144. [PubMed ID: 31516685]. [PubMed Central ID: PMC6716224]. https://doi.org/10.4103/ijpvm.IJPVM_111_18.
10.
Hedayati-Moghaddam MR, Soltanian H, Behzadifar M. Occult hepatitis B virus infection prevalence among different populations of iran: A systematic review and meta-analysis. Hepat Mon. 2020;20(6). https://doi.org/10.5812/hepatmon.101722.
11.
Rezaei N, Asadi-Lari M, Sheidaei A, Gohari K, Parsaeian M, Khademioureh S, et al. Epidemiology of hepatitis B in Iran from 2000 to 2016: A systematic review and meta-regression analysis. Arch Iran Med. 2020;23(3):189-96. [PubMed ID: 32126788].
12.
WHO. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization; 2016. Available from: https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/.
13.
Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67(1):1-31. [PubMed ID: 29939980]. [PubMed Central ID: PMC5837403]. https://doi.org/10.15585/mmwr.rr6701a1.
14.
Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, et al. Management of hepatitis B virus infection: 2018 guidelines from the Canadian association for the study of the liver and association of medical microbiology and infectious disease Canada. Can Liver J. 2018;1(4):156-217. https://doi.org/10.3138/canlivj.2018-0008.

comments